$91.17
$-2.66 (-1.45%)
End-of-day quote: 06/30/2022
NYSE:MRK

Merck (MRK)

Merck & Co., Inc. operates as a healthcare company worldwide.

If you are interested in MRK stock information, you might also be interested in competitors like BSE:500027.

With a P/E ratio of 15.00, the stock appears relatively cheap compared to its index ^SPX at the moment.

The market capitalization of Merck is currently at $230.55 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 5.64.

With one share of Merck investors achieved a dividend of $2.72. This results in a good dividend yield of 2.98%. In the last 15 years, the quarterly dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.37. The price of the stock NYSE:MRK is therefore subject to moderate fluctuations in relation to the overall market.

0.26% of MRK Stocks is owned by insiders.

For Wall Street analysts, a price target of $91.73 is currently considered realistic.

NYSE:MRK has a 52 week range of $70.89 - $94.92 and is currently trading around $91.17.

The low short sale ratio indicated that the value might increase in the foreseeable future.

6
Neutral
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
15.1
Market Cap
230.55B
LT Debt/Cap
0.04%
Price-to-book Ratio
5.64
Earnings
07/28/2022
Dividend
$2.72
Div Yld
2.98%
Dividend Growth
15 Years
Beta
0.37
Short Interest
0.92%
Forecast 1Y
24.06%
Analyst Price Target
$91.73
LTG 5Y
9.75%
52 week range
$70.89 - $94.92